Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient, prospective, comparison study in Italy

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 10, 2015, Pages 1926-1932

  Fargnoli, M C ^a   Piccioni, A ^a   Neri, L ^b   Tambone, S ^a   Pellegrini, C ^a   Peris, K ^c  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; SUNSCREEN; AMINOLEVULINIC ACID; METHYL 5-AMINOLEVULINATE; PHOTOSENSITIZING AGENT; SKIN CREAM;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DAYLIGHT PHOTODYNAMIC THERAPY; DIODE; ERYTHEMA; FACE; FEMALE; HUMAN; INTERMETHOD COMPARISON; ITALY; LOCAL SKIN REACTION; MALE; PAIN ASSESSMENT; PATIENT SATISFACTION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUSTULE; RECURRENCE RISK; RISK ASSESSMENT; SCALP; SUNLIGHT; SWELLING; TREATMENT RESPONSE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; COMPARATIVE STUDY; FACIAL DERMATOSES; KERATOSIS, ACTINIC; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PHOTOCHEMOTHERAPY; PROCEDURES; RECURRENT DISEASE; SCALP DERMATOSES; TEMPERATURE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; FACIAL DERMATOSES; FEMALE; HUMANS; ITALY; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PATIENT SATISFACTION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; RECURRENCE; SCALP DERMATOSES; SKIN CREAM; SUNLIGHT; SUNSCREENING AGENTS; TEMPERATURE;

EID: 84942278783     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13076     Document Type: Article

References (26)

1. Braathen LR, Morton CA, Basset-Seguin N, et al., Photodynamic therapy for skin field cancerization: an international consensus. International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol 2012; 26: 1063-1066.
2. Morton CA, Szeimies RM, Sidoroff A, Braathen LR,. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications-actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol 2013; 27: 536-544.
3. Morton CA, Szeimies RM, Sidoroff A, Braathen LR,. European guidelines for topical photodynamic therapy part 2: emerging indications-field cancerization, photorejuvenation and inflammatory/infective dermatoses. J Eur Acad Dermatol Venereol 2013; 27: 672-679.
4. Peserico A, Neri L, CalzavaraPinton P, et al., Key Opinion Leader (KOL) Consensus for actinic keratosis management in Italy: the AKTUAL Workshop. G Ital Dermatol Venereol 2013; 148: 515-524.
5. Wiegell SR, Haedersdal M, Philipsen PA, Eriksen P, Enk CD, Wulf HC,. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol 2008; 158: 740-746.
6. Wiegell SR, Haedersdal M, Eriksen P, Wulf HC,. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial. Br J Dermatol 2009; 160: 1308-1314.
7. Wiegell SR, Fabricius S, Stender IM, et al., A randomized, multicentre study of directed daylight exposure times of 1-12 vs. 2-12 h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp. Br J Dermatol 2011; 164: 1083-1090.
8. Braathen LR,. Daylight photodynamic therapy in private practice in Switzerland: gain without pain. Acta Derm Venereol 2012; 92: 652-653.
9. Wiegell SR, Fabricius S, Gniadecka M, et al., Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study. Br J Dermatol 2012; 166: 1327-1332.
10. Rubel DM, Spelman L, Murrell DF, et al., Daylight PDT with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional PDT in actinic keratosis treatment: a randomised controlled trial. Br J Dermatol 2014; 171: 1164-1171.
11. Pérez-Pérez L, García-Gavín J, Gilaberte Y,. Daylight-mediated photodynamic therapy in Spain: advantages and disadvantages. Actas Dermosifiliogr 2014; 105: 663-674.
12. Fai D, Romano I, Fai C, Cassano N, Vena GA,. Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in southern Italy. G Ital Dermatol Venereol 2014; Oct 3. [Epub ahead of print]
13. Peris K, Micantonio T, Piccolo D, Fargnoli MC,. Dermoscopic features of actinic keratosis. J Dtsch Dermatol Ges 2007; 5: 970-976.
14. Fargnoli MC, Kostaki D, Piccioni A, Micantonio T, Peris K,. Dermoscopy in the diagnosis and management of non-melanoma skin cancers. Eur J Dermatol 2012; 22: 456-463.
15. Olsen EA, Abernethy ML, Kulp-Shorten C, et al., A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 1: 738-743.
16. Christensen E, Warloe T, Kroon S, et al., Guidelines for practical use of MAL-PDT in non-melanoma skin cancer. J Eur Acad Dermatol Venereol 2010; 24: 505-512.
17. Wiegell SR, Wulf HC, Szeimies RM, et al., Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol 2012; 26: 673-679.
18. Szeimes RM, Basset-Seguin N, Rubel D, et al., Abstract XV World Congress on Cancers of the Skin, Edinburgh, 3-6 September, 2014.
19. Morton C, Campbell S, Gupta G, et al., Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 2006; 155: 1029-1036.
20. Tarstedt M, Rosdahl I, Berne B, Svanberg K, Wennberg AM,. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol 2005; 85: 424-428.
21. Neittaanmäki-Perttu N, Karppinen TT, Grönroos M, Tani TT, Pölönen I, Snellman E,. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded non-sponsored prospective study comparing BF-200 aminolevulinic acid with methyl-5-aminolaevulinate. Br J Dermatol 2014; 171: 1172-1180.
22. Togsverd-Bo K, Lei U, Erlendsson AM, et al., Combination of ablative fractional laser and daylight mediated photodynamic therapy for actinic keratosis in organ transplant recipients-a randomized controlled trial. Br J Dermatol 2015; 172: 467-474. doi: 10.1111/bjd.13222.
23. Wiegell SR, Skødt V, Wulf HC,. Daylight-mediated photodynamic therapy of basal cell carcinomas-an explorative study. J Eur Acad Dermatol Venereol 2013; Jan 7. doi: 10.1111/jdv.12076. [Epub ahead of print]
24. Mordon S,. A commentary on the role of skin temperature on the effectiveness of ALA-PDT in Dermatology. Photodiagnosis Photodyn Ther 2014; 11: 416-419.
25. vandenAkker JT, Boot K, Vernon DI, et al., Effect of elevating the skin temperature during topical ALA application on in vitro ALA penetration through mouse skin and in vivo PpIX production in human skin. Photochem Photobiol Sci 2004; 3: 263-267.
26. Wiegell SR, Fabricius S, Heydenreich J, et al., Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations. Br J Dermatol 2013; 168: 186-191.